CDKN2A and neoplasm: The highly metastatic LN2A LUSC model allowed us to study the aggregate roles of the 3 most common tumor suppressors in LUSC (Trp53, Pten, and Cdkn2a, Supplemental Figure 1) in a C57BL/6 immune-competent background.